FDA DrugsClass I
SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works...
Published: March 11, 2026Recall ID: D-0388-2026Category: drugsCountry: US
Reason for Recall / Hazard
Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.
Product Description & Identification
SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China
Additional Source Details
| Field | Value |
|---|---|
| City | Rosemead |
| State | CA |
| Event id | 98258 |
| Address 1 | 7214 Berne St |
| Address 2 | N/A |
| Code info | All lots within expiry |
| Postal code | 91770-3844 |
| Report date | 20260311 |
| Product type | Drugs |
| Product quantity | N/A |
| Reason for recall | Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam. |
| Voluntary mandated | Voluntary: Firm initiated |
| Recall initiation date | 20251020 |
| Initial firm notification | Press Release |
| Center classification date | 20260313 |
Overview
- Recalling FirmANTHONY TRINH, 123Herbals LLC
- StatusOngoing
- Risk LevelClass I
- DistributionUSA nationwide